The Combo Pen combines Semaglutide and Tirzepatide in a single weekly injection, used within comprehensive, medically supervised weight-management programmes.
← Weight Management & Metabolic Health
Peptide & Metabolic Therapies
Combo Pen (Semaglutide + Tirzepatide)
Combined GLP-1 and GLP-1/GIP therapy for enhanced weight-management support
Medical supervision required: This therapy is prescription-only and provided under individual medical supervision following consultation and assessment.
Potential Applications
- Enhanced weight-management support
- Appetite and metabolic regulation
- Comprehensive weight-loss programmes
The information provided on this page is intended for educational purposes only and should not be interpreted as medical advice. Individual results vary, and not all therapies are suitable for every patient. A consultation with a healthcare professional is required before commencing any treatment programme.